$43.07
▲ +0.2% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 21
▼ 4
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
Why BSX Stock Hands You So Much Cash Right Now
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?
Overview
52-week range
$47
$110
0% of range
Avg surprise (last 2)
+8.1%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
76%
EM ±9.6% · $43 · Jul 31
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.90 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.51 | — | — | — | — | financials |
| Wed Jul 23, 2025 | Jun/2025 | $0.75 | $0.72 | +4.2% | — | +4.5% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $0.75 | $0.67 | +11.9% | — | +4.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.32 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.22 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.33 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.34 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Jul 29, 2026 | Jun/2026 | BMO | $0.83 | $0.75 | +10.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $1.59B | — | $1.52B | $1.64B | $1.45B | — | $1.31B | $1.27B |
| Gross profit | $3.61B | — | $3.54B | $3.42B | $3.21B | — | $2.90B | $2.85B |
| Operating income | $1.10B | — | $1.05B | $819M | $921M | — | $733M | $520M |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $0.90 | — | $0.51 | $0.53 | $0.45 | — | $0.32 | $0.22 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.45B | $1.97B | $1.27B | $534M | $725M | $414M | $2.50B | $2.91B |
| Inventory | $3.12B | $2.94B | $2.92B | $2.86B | $2.87B | $2.81B | $2.75B | $2.61B |
| Total current assets | $8.68B | $8.79B | $8.04B | $7.12B | $7.33B | $6.92B | $8.76B | $8.99B |
| Total assets | $44.35B | $43.67B | $42.71B | $41.56B | $40.14B | $39.40B | $38.08B | $37.11B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $25.86B | $24.23B | $23.39B | $22.42B | $22.21B | $21.77B | $20.71B | $20.37B |